Wayne Brisbane, MD, studies prostate cancer and prostate cancer imaging. His focus is on optimizing medical imaging for risk stratification and treatment guidance.
Brisbane WG, Priester AM, Ballon J, Kwan L, Delfin MK, Felker ER, Sisk AE, Hu JC, Marks LS. Targeted prostate biopsy: umbra, penumbra, and value of perilesional sampling. European Urology. 2022 Sep 1;82(3):303-10.
Pensa J, Brisbane WG, Priester A, Sisk A, Marks L, Geoghegan R. A System for Co-Registration of High-Resolution Ultrasound, Magnetic Resonance Imaging, and Whole-Mount Pathology for Prostate Cancer. In 2021 43rd Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC) 2021 Nov 1 (pp. 3890-3893). IEEE
Kinnaird A, Brisbane WG, Kwan L, Priester A, Chuang R, Barsa DE, Delfin M, Sisk A, Margolis D, Felker E, Hu J. A prostate cancer risk calculator: Use of clinical and magnetic resonance imaging data to predict biopsy outcome in North American men. Canadian Urological Association Journal. 2022 Mar;16(3):E161.
Ashouri R, Nguyen B, Archer J, Crispen P, O’Malley P, Su LM, Grajo J, Falzarano SM, Acar Y, Lizdas D, Lampotang S., Brisbane, WG. Micro-Ultrasound Guided Transperineal Prostate Biopsy: A Clinic-Based Procedure. J. Vis. Exp. 2023 Feb 3;192:e64772.
Aker MN, Brisbane WG, Kwan L, Gonzalez S, Priester AM, Kinnaird A, Delfin MK, Felker E, Sisk AE, Kuppermann D, Marks LS. Cryotherapy for partial gland ablation of prostate cancer: Oncologic and safety outcomes. Cancer Medicine. 2023 Apr 1.